SciCombinator

Discover the most talked about and latest scientific content & concepts.

Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials

OPEN American journal of kidney diseases : the official journal of the National Kidney Foundation | 25 Feb 2017

SC Palmer, DJ Tunnicliffe, D Singh-Grewal, D Mavridis, M Tonelli, DW Johnson, JC Craig, A Tong and GF Strippoli
Abstract
Intravenous (IV) cyclophosphamide has been first-line treatment for inducing disease remission in lupus nephritis. The comparative efficacy and toxicity of newer agents such as mycophenolate mofetil (MMF) and calcineurin inhibitors are uncertain.
Tweets*
90
Facebook likes*
3
Reddit*
0
News coverage*
0
Blogs*
1
SC clicks
0
Concepts
Calcineurin, Immunosuppressive drug, Lupus nephritis, Mycophenolate mofetil, Systemic lupus erythematosus, Cyclophosphamide, Mycophenolic acid
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com